Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:0050610 |
| Name | oral cavity carcinoma in situ |
| Definition | An in situ carcinoma of the oral cavity that is located_in the epithelium. It is the most common cause of leukoplakia and associated with the development of squamous cell carcinoma. |
| Source | DiseaseOntology.org |
| Alt Ids | |
| Path | disease disease of cellular proliferation pre-malignant neoplasm in situ carcinoma oral cavity carcinoma in situ |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT02882282 | Phase II | Pembrolizumab | Study of Pembrolizumab (MK-3475) for High Risk Oral Intra-Epithelial Neoplasias | Completed | USA | 0 |